Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

The Oncology Institute Q2 EPS $(0.15) Misses $(0.13) Estimate, Sales $119.802M Beat $114.600M Estimate

Author: Benzinga Newsdesk | August 13, 2025 03:06pm
The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 11.76 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $119.802 million which beat the analyst consensus estimate of $114.600 million by 4.54 percent. This is a 21.53 percent increase over sales of $98.578 million the same period last year.

Posted In: TOI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist